Steamboat Capital Partners, LLC Bristol Myers Squibb CO Transaction History

Steamboat Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $5.91 Million - $6.7 Million	-102,365 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $72,993 - $80,886	-1,271 Reduced 1.23%	102,365 $6.17 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $933,968 - $1.09 Million	-17,037 Reduced 14.12%	103,636 $6.09 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $31,691 - $46,054	683 Added 0.57%	120,673 $6.73 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5.9 Million - $7.7 Million	119,990 New	119,990 $7.7 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Steamboat Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Steamboat Capital Partners, LLC with notifications on news.